Polymorphism Of The Human Platelet Antigen-5 System Is A Risk Factor For Occlusive Vascular Complications In Patients With Sickle Cell Anemia.

dc.creatorCastro, V
dc.creatorAlberto, F L
dc.creatorCosta, R N P
dc.creatorLepikson-Neto, J
dc.creatorGualandro, S F M
dc.creatorFigueiredo, M S
dc.creatorAnnichino-Bizzacchi, J M
dc.creatorSaad, S T O
dc.creatorCosta, F F
dc.date2004-Aug
dc.date2015-11-27T12:58:25Z
dc.date2015-11-27T12:58:25Z
dc.date.accessioned2018-03-29T00:59:34Z
dc.date.available2018-03-29T00:59:34Z
dc.identifierVox Sanguinis. v. 87, n. 2, p. 118-23, 2004-Aug.
dc.identifier0042-9007
dc.identifier10.1111/j.1423-0410.2004.00536.x
dc.identifierhttp://www.ncbi.nlm.nih.gov/pubmed/15355504
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/195937
dc.identifier15355504
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1296170
dc.descriptionPolymorphisms of platelet membrane glycoproteins such as human platelet antigen (HPA)-1b, HPA-2b, the -5T/C Kozak sequence and C807T have been described as risk factors for vascular disease. Vaso-occlusion episodes are a common feature of sickle cell anaemia (SCA), leading to complications such as stroke, acute chest syndrome, avascular head femur necrosis and priapism. Complex interactions are involved in vaso-occlusion, and activated platelets may play an important role. These data raised the question of whether platelet polymorphisms could be implicated in occlusive vascular complications (OVC) of SCA. In this study, 97 patients with SCA were analysed in two groups: 34 patients presenting with OVC (SCA-VC) and 63 without these complications (SCA-N). The distribution of the HPA-1, -2 and -5 systems, as well as C807T dimorphism and -5T/C Kozak sequence alleles, was evaluated using DNA-based methods. Patients of the SCA-VC group showed a higher frequency of the HPA-5b allele (0.324) compared with those of the SCA-N group (0.111) (chi2 = 13.19, P = 0.0002). None of the other polymorphisms, isolated or associated as haplotypes, demonstrated any correlation with the development of OVC in these patients. The findings of this study suggest that the HPA-5b allele is a genetic risk factor for the development of OVC in patients with SCA. This allele could be explored as a target for the development of new therapeutic approaches.
dc.description87
dc.description118-23
dc.languageeng
dc.relationVox Sanguinis
dc.relationVox Sang.
dc.rightsfechado
dc.rights
dc.sourcePubMed
dc.subjectAdolescent
dc.subjectAdult
dc.subjectAged
dc.subjectAnemia, Sickle Cell
dc.subjectAntigens, Human Platelet
dc.subjectArterial Occlusive Diseases
dc.subjectFemale
dc.subjectHumans
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectPolymorphism, Genetic
dc.subjectRisk Factors
dc.titlePolymorphism Of The Human Platelet Antigen-5 System Is A Risk Factor For Occlusive Vascular Complications In Patients With Sickle Cell Anemia.
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución